XTL Biopharmaceuticals Revenue

In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K USD. XTL Biopharmaceuticals had revenue of $405.00K in the quarter ending December 31, 2024.

Revenue

$451.00K

Revenue Growth

n/a

P/S Ratio

16.06

Revenue / Employee

$45.10K

Employees

Market Cap

6.99M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	451.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Pro	Pro	Pro
Jan 1, 2019	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SAP SE	36.49B
Siemens Aktiengesellschaft	78.91B
Allianz SE	105.02B
Deutsche Telekom AG	121.02B
Siemens Energy AG	39.08B
Rheinmetall AG	11.00B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	62.10B
Deutsche Bank Aktiengesellschaft	29.86B

Revenue Rankings